CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $111,699,119 | +79.5% | 2,907,317 | +8.2% | 0.01% | +50.0% |
| Q1 2023 | $62,228,311 | -55.3% | 2,688,048 | -49.5% | 0.00% | 0.0% |
| Q4 2022 | $139,329,294 | +187.4% | 5,317,912 | +115.7% | 0.00% | +33.3% |
| Q3 2022 | $48,476,000 | +78.5% | 2,465,719 | +58.8% | 0.00% | +50.0% |
| Q2 2022 | $27,161,000 | +4.0% | 1,552,941 | -2.8% | 0.00% | +100.0% |
| Q1 2022 | $26,127,000 | +24.4% | 1,597,002 | +24.0% | 0.00% | 0.0% |
| Q4 2021 | $21,001,000 | +17.7% | 1,287,640 | -7.9% | 0.00% | 0.0% |
| Q3 2021 | $17,841,000 | +34.4% | 1,398,169 | +48.7% | 0.00% | 0.0% |
| Q2 2021 | $13,274,000 | +222.4% | 940,106 | +254.9% | 0.00% | – |
| Q1 2021 | $4,117,000 | -9.4% | 264,900 | -7.5% | 0.00% | – |
| Q4 2020 | $4,543,000 | – | 286,457 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |